Skip to main content

Advertisement

Log in

Increase levels of apo-A1 and apo B are associated in knee osteoarthritis: lack of association with VEGF-460 T/C and +405 C/G polymorphisms

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

To investigate the genotype and allele frequency of vascular endothelial growth factor gene polymorphisms in knee osteoarthritis (OA) and their relationship with disease activity and lipid profile, we enrolled 49 knee OA patients and 75 healthy subjects (HS) as a control group. Body mass index (BMI), laboratorial assessment and genotyped by polymerase chain reaction–restriction fragment length polymorphisms (PCR–RFLP) were studied in both groups. Disease activity was determined using Lequesne and WOMAC indexes; a P value < 0.05 was considered significant. The −460 and +405 VEGF polymorphisms did not shown significant association between OA patients and HS. However, between OA patients and HS a significant differences were observed in BMI, age, apo A-I and apo B, independently of both polymorphisms studied (P < 0.05). In conclusion, increased apo A-1 and apo B levels are associated in knee OA, but the −460 T/C and +405 C/G VEGF polymorphisms are not associated with knee OA susceptibility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Bonnet CS, Walsh DA (2005) Osteoarthritis, angiogenesis and inflammation. Rheumatology 44:7–16. doi:10.1093/rheumatology/keh344

    Article  PubMed  CAS  Google Scholar 

  2. Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM et al (2000) Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 133:635–646

    PubMed  CAS  Google Scholar 

  3. Haq I, Murphy E, Dacre J (2003) Osteoarthritis. Postgrad Med J 79:377–383. doi:10.1136/pmj.79.933.377

    Article  PubMed  CAS  Google Scholar 

  4. Attur MG, Dave M, Akamatsu M, Katoh M, Amin AR (2002) Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine (editorial). Osteoarthr Cartil 10:1–4. doi:10.1053/joca.2001.0488

    Article  PubMed  CAS  Google Scholar 

  5. Honorati MC, Cattini L, Facchini A (2004) IL-17, IL-1β and TNF-α stimulate VEGF production by dedifferentiated chondrocytes. Osteoarthr Cartil 12:683–691. doi:10.1016/j.joca.2004.05.009

    Article  PubMed  Google Scholar 

  6. Brenchley PEC (2000) Angiogenesis in inflammatory joint disease: a target for therapeutic intervention (editorial review). Clin Exp Immunol 121:426–429. doi:10.1046/j.1365-2249.2000.01299.x

    Article  PubMed  CAS  Google Scholar 

  7. Mentlein R, Pufe T (2005) New functions of angiogenic peptides in osteoarthritic cartilage. Curr Rheumatol Rep 1:37–43. doi:10.2174/1573397052954226

    Article  CAS  Google Scholar 

  8. Smith JO, Oreffo ROC, Clarke NMP, Roach HI (2003) Changes in the antiangiogenic properties of articular cartilage in osteoarthritis. J Orthop Sci 8:849–857. doi:10.1007/s00776-003-0717-8

    Article  PubMed  Google Scholar 

  9. Pufe T, Lemke A, Kurz B, Petersen W, Tillmann B, Grodzinski AJ et al (2004) Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor. Am J Pathol 164:185–192

    PubMed  CAS  Google Scholar 

  10. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC et al (1991) The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266:11947–11954

    PubMed  CAS  Google Scholar 

  11. Awata T, Inoue K, Kurihara S, Ohkubo T, Watanabe M, Inukai K et al (2002) A common polymorphism in the 5′-untraslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51:1635–1639. doi:10.2337/diabetes.51.5.1635

    Article  PubMed  CAS  Google Scholar 

  12. Lin CC, Wu HC, Tsai FJ, Chen HY, Chen WC (2003) Vascular endothelial growth factor gene-460 C/T polymorphism is a biomarker for prostate cancer. Urology 62:374–377. doi:10.1016/S0090-4295(03)00268-1

    Article  PubMed  Google Scholar 

  13. Hsieh YY, Chang CC, Tsai FJ, Yeh LS, Lin CC, Peng CT (2004) T allele for VEGF gene -460 polymorphism at the 5′-untraslated region: association with a higher susceptibility to endometriosis. J Reprod Med 49:468–472

    PubMed  CAS  Google Scholar 

  14. Boiardi L, Casali B, Nicoli D, Farnetti E, Chen Q, Macchioni P et al (2003) Vascular endothelial growth factor gene polymorphism in giant cell arteritis. J Rheumatol 30:2160–2164

    PubMed  CAS  Google Scholar 

  15. Nam EJ, Han SW, Kim SU, Cho JH, Sa KH, Lee WK et al (2005) Association of vascular endothelial growth factor gene polymorphisms with Behcet disease in a Korean population. Hum Immunol 66:1068–1073. doi:10.1016/j.humimm.2005.08.238

    Article  PubMed  CAS  Google Scholar 

  16. Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N et al (2004) Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res 56:953–959. doi:10.1203/01.PDR.0000145280.26284.B9

    Article  PubMed  CAS  Google Scholar 

  17. Han SW, Kim GW, Seo JS, Kim SJ, Sa KH, Park JY et al (2004) VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology 43:1173–1177. doi:10.1093/rheumatology/keh281

    Article  PubMed  CAS  Google Scholar 

  18. Bellamy N, Buchanan WW, Goldsmith CH (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840

    PubMed  CAS  Google Scholar 

  19. Lequesne MG, Mery C, Samson M, Gerard P (1987) Indexes of severity for osteoarthritis of the hip and knee. Validation-value in comparison with other assessment test. Scand J Rheumatol Suppl 65:85–89. doi:10.3109/03009748709102182

    Article  PubMed  CAS  Google Scholar 

  20. 20. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215. doi:10.1093/nar/16.3.1215

    Article  PubMed  CAS  Google Scholar 

  21. Stürmer T, Günther KP, Brenner H (2000) Obesity, overweight and patterns of osteoarthritis: the Ulm osteoarthritis study. J Clin Epidemiol 53:307–313. doi:10.1016/S0895-4356(99)00162-6

    Article  PubMed  Google Scholar 

  22. Coggon D, Reading I, Croft P, McLaren M, Barret D, Cooper C (2001) Knee osteoarthritis and obesity. Int J Obes Relat Metab Disord 25:622–627. doi:10.1038/sj.ijo.0801585

    Article  PubMed  CAS  Google Scholar 

  23. Foye PM, Stitik TP, Chen B, Nadler SF (2000) Osteoarthritis and body weight. Nutr Res 20:899–903. doi:10.1016/S0271-5317(00)00164-0

    Article  CAS  Google Scholar 

  24. Bachorik PS, Lovejoy KL, Carroll MD, Johnson CL (1997) Apolipoprotein B and AI distributions in the United States, 1988–1991: results of the National Health and Nutrition Examination Survey III (NHANES III). Clin Chem 43:2364–2378

    PubMed  CAS  Google Scholar 

  25. Srinivasan SR, Berenson GS (1995) Serum apolipoproteins A-I and B as a markers of coronary artery disease risk in early life: the Bogalusa Heart Study. Clin Chem 4:159–164

    Google Scholar 

  26. Miyanishi K, Yamamoto T, Irisa T, Noguchi Y, Sugioka Y, Iwamoto Y (1999) Increased level of apolipoprotein B/apolipoprotein A1 ratio as a potencial risk for osteonecrosis. Ann Rheum Dis 58:514–516

    Article  PubMed  CAS  Google Scholar 

  27. Vannay A, Dunai G, Bányász I, Szabó M, Vámos R, Treszl A et al (2005) Association of genetic polymorphisms of vascular endothelial growth factor and risk for proliferative retinopathy of prematurity. Pediatr Res 57:396–398. doi:10.1203/01.PDR.0000153867.80238.E0

    Article  PubMed  CAS  Google Scholar 

  28. Suganthalakshmi B, Anand R, Kim R, Mahalakshmi R, Karthikprakash S, Namperumalsamy P et al (2006) Association if VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol Vis 12:336–341

    PubMed  CAS  Google Scholar 

  29. Ray D, Mishra M, Ralph S, Read I, Davies R, Brenchley P (2004) Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 53:861–864. doi:10.2337/diabetes.53.3.861

    Article  PubMed  CAS  Google Scholar 

  30. Lu H, Shu XO, Cui Y, Kataoka N, Wen W, Cai Q et al (2005) Association of genetic polymorphisms in the VEGF gene with breast cancer survival. Cancer Res 65:5015–5019. doi:10.1158/0008-5472.CAN-04-2786

    Article  PubMed  CAS  Google Scholar 

  31. Jacobs EJ, Feigelson HS, Bain EB, Brady KA, Rodriguez C, Stevens VL, et al (2006) Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the cancer prevention study II cohort. Breast Cancer Res 8:R22. doi:10.1186/bcr1400

  32. Lee SJ, Lee SY, Jeon HS, Park SH, Jang JS, Lee GY et al (2005) Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 14:571–575. doi:10.1158/1055-9965.EPI-04-0472

    Article  PubMed  CAS  Google Scholar 

  33. Morohashi K, Takada T, Omori K, Suzuki E, Gejyo F (2003) Vascular endothelial growth factor gene polymorphisms in Japanese patients with sarcoidosis. Chest 123:1520–1526. doi:10.1378/chest.123.5.1520

    Article  PubMed  CAS  Google Scholar 

  34. Summers AM, Coupes BM, Brennan MF, Ralph SA, Short CD, Brenchley PEC (2005) VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5. Nephrol Dial Transplant 20:2427–2432. doi:10.1093/ndt/gfi029

    Article  PubMed  CAS  Google Scholar 

  35. Papazoglou D, Galazios G, Koukourakis MI, Panagopoulos I, Kontomanolis EN, Papatheodorou K et al (2004) Vascular endothelial growth factor gene polymorphisms and pre-eclampsia. Mol Hum Reprod 10:321–324. doi:10.1093/molehr/gah048

    Article  PubMed  CAS  Google Scholar 

  36. Koukourakis MI, Papazoglou D, Giatromanolaki A, Bougioukas G, Maltezos E, Sivridis E (2004) VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer 46:293–298. doi:10.1016/j.lungcan.2004.04.037

    Article  PubMed  Google Scholar 

  37. Watson CJ, Webb NJA, Bottomley MJ, Brenchley PEC (2000) Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12:1232–1235. doi:10.1006/cyto.2000.0692

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by grant no. 45703-M to JFMV of the National Council of Science and Technology (CONACyT, México-Universidad de Guadalajara).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to José Francisco Muñoz-Valle.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sánchez-Enríquez, S., Torres-Carrillo, N.M., Vázquez-Del Mercado, M. et al. Increase levels of apo-A1 and apo B are associated in knee osteoarthritis: lack of association with VEGF-460 T/C and +405 C/G polymorphisms. Rheumatol Int 29, 63–68 (2008). https://doi.org/10.1007/s00296-008-0633-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-008-0633-5

Keywords

Navigation